In type-2 diabetes cases, the circuit of ESR1, BRCA and CYP19 genes does not show mutation and the upregulation of estrogen signaling may easily compensate the difficulties of glucose uptake circuit. This evidence concerns the gene CYP19A1 and type 2 diabetes mellitus.